Solid Biosciences Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | — | — | — | $8.1 | $13.6 |
| Operating income | -$179.2 | -$129.7 | -$104.3 | -$106.5 | -$72.3 |
| Net income | -$174.3 | -$124.7 | -$96.0 | -$86.0 | -$72.2 |
| Cash Flow Statement | |||||
| Free cash flow | -$157.4 | -$100.7 | -$95.7 | -$101.0 | -$79.0 |
Shares outstanding 107.2M · Free float 55.9%
Annual filing data through FY ended December 31, 2025; float as of October 13, 2026.
Solid Biosciences Widens Third-Quarter Loss